Bayer's CEO Bill Anderson plans to cut bureaucracy and management layers to achieve a more innovative company. He aims to save 2 billion euros annually by 2026. Critics argue that these changes reflect transformation theater rather than genuine improvement. Bayer has faced long-standing issues such as significant debt and lawsuits from the Monsanto acquisition. Despite aggressive announcements, the company's stock remains low, raising questions about the effectiveness of the rapid changes implemented under Anderson's leadership. True transformation requires a sense of safety rather than disruptive urgency.
Bayer's CEO Bill Anderson announced a plan to eliminate bureaucratic layers to cut costs, but critics argue this approach lacks genuine transformation and clarity on addressing core issues.
The urgency created by Anderson's manifesto comes in the context of long-standing issues at Bayer, including debt accumulation and the impact of litigation arising from past acquisitions.
Collection
[
|
...
]